Company Quick10K Filing
Levi Strauss
10-Q 2020-05-24 Filed 2020-07-07
10-Q 2020-02-23 Filed 2020-04-07
10-K 2019-11-24 Filed 2020-01-30
10-Q 2019-08-25 Filed 2019-10-08
8-K 2020-07-16 Officers, Regulation FD
8-K 2020-07-07 Earnings, Exit Costs, Officers, Exhibits
8-K 2020-04-14
8-K 2020-04-08
8-K 2020-04-02
8-K 2020-01-30
8-K 2020-01-28
8-K 2020-01-10
8-K 2019-10-08

Levi Strauss Financials

LEVI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Beyond Meat (BYND) 10,014 33% -2,676.5 -3% 455 78 199 66 -12 -4 9,732
World Gold Trust (GLDW) 9,923 71.4 13% 1,051 0 0 0 139 139 9,923
Simply Good Foods (ATK) 9,838 48% 111.2 5% 1,125 295 492 235 53 88 9,787
Avantor (AVTR) 8,937 32% 34.8 -0% 9,763 7,408 3,036 965 -27 403 14,033
Tradeweb Markets (TW) 8,823 0% 52.9 1% 5,623 1,135 391 0 73 159 8,432
Haha Generation (HAHA) 8,365 1,375,364.1 34% 0 0 0 0 0 0 8,365
Fibria Celulose (FBR) 8,093 0% 38,693 24,043 0 0 0 0 4,853
Levi Strauss (LEVI) 7,570 54% 11.3 10% 4,139 2,671 5,786 3,097 397 681 7,712
Cheniere Energy Partners (CQH) 7,546 0% 21.1 40,650% 1 0 106 0 357 358 7,546
Scana (SCG) 6,991 0% -64.4 -3% 17,654 6,357 4 0 -589 -214 13,783
Great Plains Energy (GXP) 6,623 9.2 2% 12,448 3,898 0 0 201 986 9,090
DCT Industrial Trust (DCT) 6,436 0% 22.8 3% 4,083 2,007 434 0 125 360 8,200
Energen (EGN) 6,424 0% 9.0 7% 5,724 2,116 1,382 0 423 814 7,362
EQGP Holdings (EQGP) 6,194 0% 7.5 8% 9,268 4,213 867 0 701 829 6,188
Dynatrace (DT) 5,863 73% -34.1 -24% 1,933 1,047 252 183 -466 -182 6,221
Michael Kors (KORS) 5,778 61% 11.9 4% 8,393 5,981 5,570 3,374 337 672 8,010
Validus (VR) 5,456 -20% -37.2 -1% 15,499 9,928 2,881 -578 -193 -141 5,235
Envision Healthcare (EVHC) 5,406 0% -9.8 -13% 12,313 7,687 8,144 0 -1,555 -960 9,409
Foundation Medicine (FMI) 5,074 0% -42.1 -73% 193 202 201 0 -142 -119 5,019
Adaptive Biotechnologies (ADPT) 5,039 76% -180.1 -3% 917 331 48 37 -30 -28 4,961

Balance Sheet ($MM)2011-08-282011-11-272012-02-262012-05-272012-08-262012-11-252013-02-242013-05-262013-08-252013-11-242014-02-232014-05-252014-08-242014-11-302015-03-012015-05-312015-08-302015-11-292016-02-282016-05-292016-08-282016-11-272017-02-262017-05-282017-08-272017-11-262018-02-252018-05-272018-08-262018-11-252019-02-242019-05-262019-08-25
Cash231205238278315406450390382489503386367298203285273319271360272376369438491634590699613713623861864
Accounts Receivable539655533366439501399343420447388342441482369326439498389335445479407309447485428342487534634574722
Inventory731611641506560519572539625604666687722601594613675607740790851716767781826759826843938884914895936
PP&E5085024864754581,2424514464361,2164234103971,1773723703761,2023863833851,2503803903891,3764154134201,435464481499
Assets3,2883,2803,2112,8933,0073,1703,1472,9813,1453,1273,1462,9863,0582,9242,6912,7392,8772,8842,8382,9182,9892,9872,9302,9553,2223,3553,2183,2203,4183,5433,7083,9094,139
Accounts Payable249205215165231226246208250255250239262235197240279238267282270270257274300290305329362351330339358
Long-Term Debt1,8561,8181,8141,6901,6621,6691,5981,4881,5021,5041,5101,3031,2971,0921,0921,0511,0521,0381,0411,0421,0468381,0071,0071,0368041,0621,0341,0268501,0181,0111,007
Liabilities3,3843,4293,3012,9993,0823,2643,1612,9413,0412,9142,9172,7402,7602,6922,4742,5022,5902,4842,4402,4782,4462,3962,3372,3472,5072,5252,5022,4382,5382,5762,6992,5882,671
Stockholders' Equity-115-166-105-119-87-107-2910711721882002441531361631983303193654585105055306206975505846476606791,3141,461
Income Statement ($MM)2011-08-282011-11-272012-02-262012-05-272012-08-262012-11-252013-02-242013-05-262013-08-252013-11-242014-02-232014-05-252014-08-242014-11-302015-03-012015-05-312015-08-302015-11-292016-02-282016-05-292016-08-282016-11-272017-02-262017-05-282017-08-272017-11-262018-02-252018-05-272018-08-262018-11-252019-02-242019-05-262019-08-25
Revenue1,2041,3161,1651,0471,1011,2971,1471,0991,1411,2951,1301,0821,1541,3881,0551,0121,1421,2851,0561,0121,1851,3001,1021,0681,2681,4661,3441,2461,3941,5921,4341,3131,447
Cost of Revenue635692616566580648555550568658554548592708518512569627497494592640537509612683606575653744652613680
Gross Profit569624549481521649592549573637576534562680537500573658560517593659565558657783738671742847783700767
R&D
SG&A489532439435434558410449455571425446455581425450455494441459449517456496510633564594583720582638596
Tax1413241824214829209161723520831423311333929142822168233238353627
Net Income324449302853107485717501151-638125810266319896601889117-19771309714729125
Cash Flow ($MM)2011-08-282011-11-272012-02-262012-05-272012-08-262012-11-252013-02-242013-05-262013-08-252013-11-242014-02-232014-05-252014-08-242014-11-302015-03-012015-05-312015-08-302015-11-292016-02-282016-05-292016-08-282016-11-272017-02-262017-05-282017-08-272017-11-262018-02-252018-05-272018-08-262018-11-252019-02-242019-05-262019-08-25
Cash Operating-15105223881151431112013736379152386581084657-0204491687723166161-235610644
Cash Investing-26-21-13-16-25-24-24-15-29-15-13-19-26-25-11-18-27-185-23-32-16-33-27-49-41-38-40-80-63-55
Cash Financing25-54-159-36-3-76-143-9-3-7-143-7-184-97295-32-7425-67-58-43-700-39-74-6-16-6819916